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A B S T R A C T
It is still a matter of debate whether sentinel node biopsy might replace neck dissection in patients with clinically neg-
ative neck lymph nodes who suffer from oral squamous cell carcinoma. In 30 patients (26 male, 4 female, average age
59.4 years) with oral squamous cell carcinoma we performed ultrasound guided punction of the lymph nodes which were
lymphoscintigraphically seen together with histopatological analysis of the dissected node. Sentinel lymph node was
seen in 93% cases. By use of lymphoscintigraphy sentinel node was verified in 23 patients. Ultrasound guided punction
showed presence of regional disease in 10% of cases, whereas sentinel biopsy revealed 23 of the converted necks. Histo-
pathological findings were positive in 33% of our patients. The results of this study revealed that sentinel biopsy did not
reveal 27% of the patients with positive neck histopathology. In conclusion, sentinel node biopsy should be performed in
selective cases as in some localizations it is easier to perform neck dissection in comparison to the sentinel node biopsy.
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Introduction
The prevalence of oral squamous cell carcinoma is
increasing1. Clinically negative necks in early stage of
oral squamous cell carcinoma (OSCC) tend to harbor oc-
cult disease within cervical lymph nodes in 20–30% of
cases2. Sentinel node biopsy (SNB) has been proposed for
staging of the cN0 neck in early oral/oropharyngeal squa-
mous cell carcinomas (SCC). Because SNB is a minimally
invasive procedure, it is thought to be associated with
less morbidity than elective neck dissection. The man-
agement of the clinically and radiologically negative neck
(cN0) in patients with early oral and oropharyngeal
squamous cell carcinoma (OSCC) is still a matter of de-
bate, though most centers favor an active policy and per-
form elective neck dissection (END) for staging of the
neck and removal of occult disease. In the past decade
SNB has been successfully implemented in early stage
head and neck carcinomas3. However, Pattani et al.2 con-
cluded that it is unclear if sentinel node biopsy results in
any comparable improvement in survival in comparison
to wait and see policy. Therefore we compared ultra-
sound guided punction of lymph nodes lymphoscintigra-
phically seen together with histopathological analysis of
the dissected nodes.
Materials and Methods
This study was approved by the Ethical Committee
according to Helsinki II. There were 30 patients with
oral carcinoma with an average age of 59.4 yrs. There
were 26 (86%) male patients and 4 (14%) female patients.
In 14 (47%) patients modified radical neck dissection was
performed and in 16 (53%) patients classic radical neck
dissection was performed. Most frequently tumors were
located on the tongue (36.7%), followed by floor of the
mouth (23.3%), and in the remaining 20% of the patients
the tumor was located on the tonsil. Retromolar area and
oropharynx were affected in two patients (6.7%) and base
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of the tongue in one patient as well as buccal carcinoma
seen in one patient (3.3%). T1 staging had one patient
(1%), T2 staging had 22 patients (73.3%) and T3 staging
had 7 patients (23.3%).
Comparison between lymph node size was tested by
use of t-test for dependent samples whereas number of
tested lymph nodes after dissection was tested with t-test
for independent samples. In both cases variables were
normally distributed which was confirmed by Shapiro-
-Wilks test. The localization and tumor size with regard
to the spread into regional lymph nodes were tested with
c2-test. Statistical analysis was performed on Statistica
6.0 (Statsoft, Tulsa, USA). As histopathological analysis
of the lymph nodes revealed highest number of positive
lymph nodes and it was used as a standard. Afterwards,
sensitivity and specificity for employed methods was cal-
culated and compared with McNemar test for dependent
pairs of proportion.
Results
Out of 30 analysed patients in 28 patients sentinel
lymph node was identified (93%). In 23 patients in whom
nodes were lymphoscintigraphically seen, these nodes
were also shown by intraoperative gamma probe. In
seven patients lymphoscintigraphy didnt show sentinel
node and five were identified with gamma probe. In 24
patients in whom nodes were recorded as hot, radioactiv-
ity was seen in one region whereas in four patients radio-
activity was recorded in two regions. In 17 patients re-
gion III was identified, followed by region II (6 cases). In
two patients regions III and IV were identified and in the
remaining two regions were seen IV and V and I and V
respectively. In patients whom lymph node was not seen
lymphoscintigraphically the suspected lymph node was
punctured. The size of the lymph nodes seen by ultra-
sound varied between 9–22 mm. The average size of the
measured lymph node seen by ultrasound was 13 mm.
Cytological analysis was performed on several measur-
ments. Firstly out 30 patients, only in one patient was the
punctate of the lymph node positive. In five patients im-
print cytology was positive. In those five patients smears
stained according to Giemsa and Papanicolau were posi-
tive as well as immunohistochemistry on cytokeratin.
Cytological punction as well as imprint cytology were ne-
gative in all other patients.
Final results of the sentinel lymph nodes localisation
were obtained by combination of lymphoscintigraphy and
intraoperative display by use of mobile gamma probe. By
lymphoscintigraphy we showed 23 localisations of poten-
tial lymph nodes. Out of remaining seven patients who
were not detected, in five we managed to detect sentinel
nodes, therefore in 28 patients sentinel lymph nodes
were identified. In 30 patients, 44 lymph nodes were ex-
tracted and were considered as sentinel lymph nodes.
The average size of the sentinel nodes was 12.3 mm
(range 5–30 mm). Twenty four sentinel nodes were found
in the region III, 17 in the region II and three in the re-
gion I. By use of gamma probe no sentinel nodes were
seen in the region IV and V.
In our patients the number of sentinel positive lymph
nodes varied between one to five. The most frequent
finding was one sentinel node in 24 patients (80%). In
two patients two lymph nodes were extracted as sentinel
lymph nodes (6.7%) and in one patient we extracted
three lymph nodes (3.3%) and in one we extracted four
lymph nodes (3.3%). In two patients we extracted 5
lmyph nodes (6.7%) which were considered as sentinel
lymph nodes. Average number of extracted lymph nodes
per patient was 1.5 which were considered as sentinel
lymph nodes. Positive lymph nodes were seen in 8 pa-
tients (27%). Average number of extracted lymph nodes
per patient was 1.5 and they were considered as sentinel
nodes. Positive sentinel nodes were seen in 8 patients
(27%). In four patients positive sentinel node was the
only positive lymph node. In two patients (6%) was senti-
nel lymph node negative whereas in the dissected neck
the same node was found to be positive. Therefore the
false negative finding was observed. In one patient senti-
nel node biopsy as well as results of the dissected neck
were negative, whereas during the operation positive
lymph node was found parapharyngeally. In total we saw
three false negative findings. Two referred to negative
sentinel nodes whereas in one patient (no matter of the
negative sentinel and dissected neck) one positive node
parapharyngeally during operation was found.
In histopathological samples of the lymph nodes, 14 to
45 lymph nodes per patient were isolated. An average
number of the lymph nodes was 29.72. In ten patients
positive lymph nodes in dissected tissue were found and
consequently 6 patients had PN1 (instead of N0) and
four patients had PN2 (instead of N0).
There was significant difference between imprint cy-
tology and cytological aspiration according to Mc Nemar
analysis (p=0.0455). There was no difference between
sentinel biopsy and imprint cytology according to Mc
Nemar analysis (p=0.0833). Additionally there was no
difference between histopathology and sentinel biopsy
finding (p=0.1573). There was a significant difference
between histopathology and imprint cytology as a meth-
od while diagnosing negative neck (p=0.0253).
There were no significant differences between differ-
ent tumor localizations and metastases. Probability of
metastases was not dependent upon T staging. The prob-
ability of metastizing into regional nodes was independ-
ent upon size of the sentinel lymph node as well as num-
ber of the examined nodes.
There was no significant difference between sentinel
lymph node measured with ultrasound and sentinel lymph
node on the histopathology finding.
Discussion
Gurney et al.4 performed total of 122 neck dissections
in 109 patients. Additional positive nodes were found in
34.4% of cases (42/122: 18 same, 21 adjacent, and 3 non-
adjacent neck level). Additional nodes, especially if out-
side the sentinel node basin, had an impact on outcome.
The results are preliminary but suggest that both the
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number and the position of positive sentinel nodes may
identify different prognostic groups that may allow fur-
ther tailoring of management plans. Murer et al.5 inves-
tigated 33 patients after SNB and 29 after elective neck
dissection. SNB is associated with significantly less post-
operative morbidity and better shoulder function than
elective neck dissection. The same authors5 concluded
that patients with nodal negative early SCC of the oral
cavity should be offered SNB. However, the results of
this study show that sentinel node biopsy has drawbacks,
therefore we wouldn’t recommend it as the results of this
study revealed that sentinel biopsy did not reveal 27% of
the patients with positive neck histopathology. Contrary
to our results, Liu et al.6, Dequanter et al.7, Edkins et al.8
reported that SNB has 100% sensitivity and specificity in
oral tongue carcinoma. It might be that sentinel is an ex-
cellent method for detection of oral carcinoma and that
different results are obtained when oropharyngeal carci-
nomas are included.
Yamauchi et al.9 reviewed 22 patients with clinically
T1/T2, N0. Three of 11 patients (27%) in the watchful
waiting group developed regional recurrence and under-
went neck dissection. Only 1 of 11 patients (9.1%) in the
sentinel node navigation surgery (SNNS) group devel-
oped regional recurrence. Although the groups did not
significantly differ, the SNNS group tended to have less
regional recurrence. SNNS should be the third strategy
for managing early oral tongue carcinoma.
Broglie et al.10 performed analysis of 79 patients (67%
male, median age 60 years, age range 34–87 years). Lym-
phatic mapping consisted of preoperative lymphoscinti-
graphy, single photon emission computed tomography
(SPECT/CT), and intraoperative use of a handheld gamma
probe. Twenty-nine of 79 patients (37%) had positive
sentinel nodes (SN). Six of 29 (21%) patients showed iso-
lated tumor cells, 14/29 (48%) micrometastases, and 9/29
(31%) macrometastases. Only the difference in DSS
achieved statistical significance. The neck control rate
after 5 years was 96% in SN-negative and 74% in SN-pos-
itive patients. This difference was statistically signifi-
cant. SNB is a safe and accurate staging modality to se-
lect patients with clinically stage I/II OSCC with occult
lymph node disease for elective neck dissection (END).
Patients with negative SN and no END achieve an excel-
lent neck control rate which compares favorably with re-
ports on primary END. The neck control rate in SN-neg-
ative patients is superior to that in SN-positive patients,
which is reflected in superior DSS.
Our results show that in 93% of our patients positive
sentinel lymph node was identified which was in concor-
dance with the results of Pitman et al.11 and also Krag et
al.12. However, Krag et al.12 reported that detection is
highly dependable upon surgeon as on the same sample
the percentage of sentinel node identification varied be-
tween 79–98%.
Nieuwenhuis13 reported that ultrasound guided cytol-
ogy reduces the need for sentinel biopsy for 50%. This
finding is opposite to our results as we found that only
one patient with positive histopathological finding had
positive aspiration cytology finding by use of ultrasound.
Aspiration cytology was significantly more sensitive
when compared to imprint cytology when diagnosing
clinically negative neck. According to our results aspira-
tion cytology guided by ultrasound is not method of
choice in clinically negative neck. Sentinel node biopsy
especially in jugular chain might carry serious conse-
quences upon vital structures.
The number of extracted sentinel nodes in our study
was in concordance with other studies14 and varied be-
tween one to five nodes.
Skip metastases were seen in two patients within this
study (6.7%). Our results are in concordance with the re-
sults of Byers et al.15 who reported that 15.7% of the pa-
tients had skip metastases. These findings might explain
recurrences after neck dissection which didn’t include all
five lymph node regions.
One has to bear in mind that most studies so far have
showed results based on the extraction of sentinel nodes
during neck dissection, but not based solely on the senti-
nel node identification. Last but not least, we are still un-
able to confirm whether sentinel might decrease morbidity
and increase patients survival. More studies are needed
regarding sentinel node efficacy based on the percent-
ages of the regional recurrences during five year period.
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EVALUACIJA SENTINEL BIOPSIJE LIMFNIH ^VOROVA U ORALNOM KARCINOMU
S A @ E T A K
Jo{ uvijek nije poznato da li sentinel biopsija limfnih ~vorova mo`e zamijeniti disekciju vrata u bolesnika koji boluju
od karcinoma usne {upljine i imaju klini~ki negativne limfne ~vorove na vratu. U 30 bolesnika oboljelih od oralnog
planocelularnog karcinoma (26 mu{karaca i 4 `ene, prosje~ne dobi od 59,4 godine) je napravljena punkcija limfnih
~vorova uz pomo} ultrazvuka koji su vi|eni i limfoscintigrafski te uz patohistolo{ku analizu diseciranih ~vorova. Senti-
nel limfni ~vorovi su vi|eni u 93% slu~aja. Upotrebom limfoscintigrafije su sentinel pozitivni ~vorovi verificirani u 23
pacijenta. Punkcija uz pomo} ultrazvuka je pokazala prisutnost regionalne bolesti u 10% slu~ajeva, dok su uz pomo}
sentinel biopsije otkrivena 23 konvertirana vrata. Patohistolo{ki nalaz je bio pozitivan u 33% bolesnika. Rezultati ovog
istra`ivanja pokazuju kako se sentinel biopsijom nije otkrilo 27% bolesnika sa pozitivnim patohistolo{kim nalazom
limfnih ~vorova vrata. Zaklju~no, sentinel biopsija limfnih ~vorova se treba napraviti u izdvojenim slu~ajevima jer je na
nekim mjestima lak{e napraviti disekciju vrata u odnosu na sentinel biopsiju limfnih ~vorova.
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